Tachyphylaxis With Sustained Apraclonidine Use in the Treatment of Ptosis Associated With Horner Syndrome
J Neuroophthalmol
.
2023 Dec 1;43(4):e245-e246.
doi: 10.1097/WNO.0000000000001611.
Epub 2022 Jun 14.
Authors
Jessica A Kraker
1
,
Deena A Tajfirouz
,
M Tariq Bhatti
,
John J Chen
Affiliation
1
Mayo Clinic Department of Ophthalmology (JAK, DAT, MTB, JJC), Rochester, Minnesota; and Mayo Clinic Department of Neurology (MTB, JJC), Rochester, Minnesota.
PMID:
36279499
DOI:
10.1097/WNO.0000000000001611
No abstract available
MeSH terms
Blepharoptosis* / drug therapy
Blepharoptosis* / etiology
Clonidine / therapeutic use
Horner Syndrome* / complications
Horner Syndrome* / diagnosis
Horner Syndrome* / drug therapy
Humans
Tachyphylaxis
Substances
apraclonidine
Clonidine